1CM Inc
1CM Inc., a multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada. The company operates cannabis and liquor retail stores. It also offers One Cannabis Market, a technology platform that provides B2B and B2C solutions, including last mile delivery, digital signage, big data analytics, and wholesale clearing services. The company … Read more
1CM Inc (MILFF) - Net Assets
Latest net assets as of November 2025: $29.62 Million USD
Based on the latest financial reports, 1CM Inc (MILFF) has net assets worth $29.62 Million USD as of November 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($42.80 Million) and total liabilities ($13.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $29.62 Million |
| % of Total Assets | 69.2% |
| Annual Growth Rate | 71.5% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 117.49 |
1CM Inc - Net Assets Trend (2019–2025)
This chart illustrates how 1CM Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 1CM Inc (2019–2025)
The table below shows the annual net assets of 1CM Inc from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-08-31 | $28.87 Million | +4.12% |
| 2024-08-31 | $27.73 Million | +12.73% |
| 2023-08-31 | $24.60 Million | +59.91% |
| 2022-08-31 | $15.38 Million | +445.36% |
| 2021-08-31 | $-4.45 Million | -178.03% |
| 2020-08-31 | $-1.60 Million | -241.27% |
| 2019-08-31 | $1.13 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to 1CM Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 407424300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $68.90 Million | 238.66% |
| Total Equity | $28.87 Million | 100.00% |
1CM Inc Competitors by Market Cap
The table below lists competitors of 1CM Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Atech OEM
TWO:6109
|
$20.23 Million |
|
Iron Bear Resources Ltd
AU:IBR
|
$20.24 Million |
|
Singtex Industrial Co Ltd
TWO:4433
|
$20.24 Million |
|
Lumens Co. Ltd
KQ:038060
|
$20.25 Million |
|
White Gold Corp
OTCQX:WHGOF
|
$20.21 Million |
|
Koleksiyon Mobilya Sanayi AS
IS:KLSYN
|
$20.21 Million |
|
Asset Five Group PCL
BK:A5
|
$20.21 Million |
|
KCI Limited
KQ:036670
|
$20.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 1CM Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,725,693 to 28,867,441, a change of 1,141,748 (4.1%).
- Net income of 484,849 contributed positively to equity growth.
- Other factors increased equity by 656,899.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $484.85K | +1.68% |
| Other Changes | $656.90K | +2.28% |
| Total Change | $- | 4.12% |
Book Value vs Market Value Analysis
This analysis compares 1CM Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.88x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 15.70x to 0.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-08-31 | $0.01 | $0.22 | x |
| 2020-08-31 | $-0.02 | $0.22 | x |
| 2021-08-31 | $-0.05 | $0.22 | x |
| 2022-08-31 | $0.14 | $0.22 | x |
| 2023-08-31 | $0.21 | $0.22 | x |
| 2024-08-31 | $0.24 | $0.22 | x |
| 2025-08-31 | $0.25 | $0.22 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently 1CM Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.68%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.66%
- • Asset Turnover: 1.75x
- • Equity Multiplier: 1.45x
- Recent ROE (1.68%) is above the historical average (-353.51%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -2444.00% | -24074.18% | 0.02x | 4.50x | $-28.65 Million |
| 2020 | 0.00% | -3873.96% | 0.01x | 0.00x | $-2.68 Million |
| 2021 | 0.00% | -1333.45% | 0.04x | 0.00x | $-4.17 Million |
| 2022 | -30.74% | -561.10% | 0.03x | 1.84x | $-6.27 Million |
| 2023 | -3.72% | -2.59% | 1.04x | 1.38x | $-3.37 Million |
| 2024 | 2.22% | 1.08% | 1.44x | 1.44x | $-2.16 Million |
| 2025 | 1.68% | 0.66% | 1.75x | 1.45x | $-2.40 Million |
Industry Comparison
This section compares 1CM Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 1CM Inc (MILFF) | $29.62 Million | -2444.00% | 0.45x | $20.23 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |